You are here
- Home
- Therapy Areas
- Neuroscience
An open label positron emission tomography (PET) study with (11C)flumazenil to determine central GABAA receptor occupancy of AZD6280 after oral administration to healthy volunteers.
- Disease
- anxiety, schizophrenia
- Drug Name
- AZD6280
- Generic Name
- AZD6280
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- I
- Start Date
- Feb 26, 2008
- Study Name
- D0850C00011
- Study Id
- D0850C00011
- ClinicalTrials.gov ID
- NCT00681746
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
- Sep 14, 2009
